Ketamine advertisements are popping up all around us. With few regulations in place, might we be witnessing another opioid ...
20h
Money Talks News on MSNPsychedelic Mushrooms Show Promise in Treating Mental Health ConditionsPsychedelic mushrooms, containing the active ingredient psilocybin, have shown remarkable potential in treating various ...
The government is preparing to fund the use of MDMA and psylocibin, otherwise known as ecstasy and magic mushrooms, as a ...
Psychedelics have been recreational substances for decades. Now, they're entering the mainstream of psychiatric treatment.
We recently published an article titled Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025. In this article, we are ...
Three of the RSU grants vests ratably in equal installments on the first, second, and third anniversaries of the grant date, and one of RSU grants vests ratably in equal installments on the second, ...
NEW YORK, NY / ACCESS Newswire / March 3, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Supernus ...
Psychedelics are a subclass of hallucinogenic drugs. In the last 10 years, use of drugs such as ketamine, psilocybin, ayahuasca, and MDMA or ecstasy increased in Canada and the United States. In the U ...
17h
Zacks.com on MSNNRx Pharmaceuticals to Post Q4 Earnings: How to Play the Stock?NRx Pharmaceuticals NRXP is expected to report its fourth-quarter 2024 results soon. The Zacks Consensus Estimate for NRXP’s ...
Hawaii’s Senate has approved a proposal to create a special fund that would support clinical research into psychedelic-assisted treatment using substances such as psilocybin and MDMA, both of which ...
Discover how unresolved emotional trauma creates measurable physical damage, from sleep disruption and chronic inflammation ...
Depression is a common condition that has a significant disease burden on those affected. While medication and psychotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results